Best in Biotech 20 Feb 2024
Biotechs in the US Capital: seven key players based in Washington DC
Dive into the vibrant biotech scene of Washington D.C. with our article spotlighting the pioneering biotech companies leading the charge.
biotech startup
- Latest Posts
Best in Biotech 8 Feb 2024
Fourteen biotech companies spearheading the antibody drug conjugate industry
The antibody-drug conjugate market has gained significant traction recently. Discover some of the top ADC companies in the industry.
Best in Biotech 6 Feb 2024
16 UK biotech companies you should know about
Take a closer look at 16 of the top U.K. biotech companies, as the nation’s biotech scene is now one of the most vibrant in Europe.
Best in Biotech 30 Jan 2024
Navigating German biotech: 13 key players to know
The German biotech ecosystem is well established despite the challenges it is facing. Discover thirteen key Germany-based biotech companies.
Best in Biotech 29 Jan 2024
10 biotech accelerators shaping tomorrow’s innovations
Here are 10 biotech accelerators that are dedicated to fueling entrepreneurial goals of setting up successful life science companies.
Best in Biotech 23 Jan 2024
19 French biotechs you should know about
France is at the forefront of innovative biotech and Paris has become a vibrant startup ecosystem. Here are 19 top French biotech companies!
ADVERTISEMENT
ADVERTISEMENT
Podcast 12 Jan 2024
Could natural killer cells transform Alzheimer’s treatment?
Join Dr. Paul Song, CEO of NKGen Biotech, in a podcast exploring the revolutionary use of NK cells for Alzheimer’s treatment.
Best in Biotech 11 Jan 2024
Ten NK cell therapy companies to look out for this year
As biotechs raise funding to advance their NK cell therapy candidates in the clinic, here are ten companies in the space to watch out for.
Best in Biotech 9 Jan 2024
Four Pune-based biotech companies you should know about
Explore Pune’s dynamic biotech landscape and delve into the innovative work of the city’s most prominent biotech companies!
Best in Biotech 21 Dec 2023
Five companies racing to bring their NASH treatments toward the finish line
NASH is a severe form of non-alcoholic fatty liver disease (NAFLD), where fat builds up on the liver, potentially leading to liver damage or cirrhosis. With no U.S. Food and Drug Administration (FDA)-approved treatments for the disease, many NASH companies are currently attempting to bring their candidates toward approval. In this article, we take a […]
Best in Biotech 19 Dec 2023
Nine biotech companies to watch in 2024
2024 is shaping up to be an exciting year for the industry. Discover nine biotech companies to keep an eye on in 2024.
Podcast 24 Nov 2023
Company exits stealth to launch molecular gates
On this week’s podcast we have a conversation with Jordi Mata-Fink, co-founder and chief executive officer of Gate Bioscience. Gate Bioscience is a U.S.-based biotechnology company creating a new class of medicines called Molecular Gates. Founded in 2021, Gate is emerging from stealth with a novel scientific platform and $60 million in Series A funding […]
ADVERTISEMENT
